Elon Musk's two flagship companies may combine, but negotiations and regulatory reviews could stretch for years. Here's what decision-makers should watch.

The CSRC green light lets Citigroup go solo in China's capital markets, just weeks before Xi and Trump meet at APEC.

Late-stage win sets up regulatory talks and could reshape how cancer is treated - and how biotech investors value mRNA platforms.

Vast resources and a huge population still attract capital, but regulatory chaos is pushing executives to look elsewhere.

A succession crisis is forcing retiring owners to hand over cafés, farms, and guesthouses to a new generation, often for nothing.

Tesla will sell its autonomous two-seater by end of year while federal regulators investigate whether it meets vehicle safety standards.

Nvidia's DSX pods, fully wired modular containers, promise to shrink AI factory deployment from six months to two weeks, starting with Vera Rubin systems in 2027.

The streaming giant's latest earnings show profit growth, but flat engagement in the U.S. and Canada signals a ceiling for its core market.

The U2 frontman reveals the band's pricing philosophy: affordable front rows, premium prices for the wealthy, as concert costs hit record highs and regulators circle Live Nation.

The federal ban on the low-cost Chinese model signals a new front in AI supply-chain security, with compliance and vendor implications.

Nick Cammarata's Goodfire post has the AI world split - if he's right, monitoring frontier models just got a lot easier.

The Claude maker's 5% share pledge, worth $48bn, is a bid to win over regulators and investors before its stock market listing.